---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD, Walsh KM, Bengtsson H, Hong C, Oberndorfer S, Roetzer T, Smirnov IV, Clarke JL, Aghi MK, Chang SM, Nelson SJ, Woehrer A, Phillips JJ, Solomon D, Costello JF. Genomic analysis of the origins and evolution of multicentricdiffuse lower-grade gliomas. Neuro Oncol. 2017 Oct 25

Mazor T., Chesnelong C., Pankov A., Jalbert LE., Hong C., Hayes J., Smirnov IV., Marshall R., Souza C., Shen Y., Viswanath P., Noushmehr H., Ronen SM., Jones SJ., Marra MA., Cairncross JG, Perry A., Nelson SJ., Chang SM., Bollen AW., Molinaro AM., Bengtsson H., Olshen AB, Weiss S., Phillips JJ., Luchman HA., Costello JF. PNAS 2017 114(40):10743-10748. 

Mohan N., Kwiatkowska A., Bhaskaran V., Hayes J., Hu Bin. and Viapiano M. S. Tumor-derived fibulin-3 activates pro-invasive NF-kappa B signaling in glioblastoma cells and their microenvironment. Oncogene 2017 36(34):4875-4886. 

Kuang R., Jahangiri A., Mascharak S., Nguyen A., Ankush, Flanigan CPM., Yagnik G., Wagner JR., De Lay M., Carrera D., Castro BA., Hayes J., Sidorov M., and Aghi MK. et al. GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. JCI insight 2017, 2(2):e88815.

Hayes J., Thygesen H., Gregory W., Westhead DR., French P., Van Den Bent M., Lawler SE., Short S., et al. A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab. Molecular Oncology 2016, 10(8):1296-304.

Hayes J., Thygesen H., Droop A., Hughes TA., Westhead DR., Lawler SE., Wurdak H., Short S.  Prognostic microRNAs in high-grade glioma reveal a link to OP differentiation. Oncoscience 2014, 2(3):252-62.  

Hayes J., Thygesen H., Tumilson C., and Lawler SE. et al. Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature.
Molecular Oncology 2014, 9(3):704-14.

Hayes J., Peruzzi P., Lawler SE. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 2014, 20:460-469. (One of TMMs top ten articles for 2014).

Peruzzi P, Bronisz A, Nowicki MO, Wang Y, Ogawa D, Price R, Nakano I, Kwon CH, Hayes J, Lawler SE, Ostrowski MC, Chiocca EA, Godlewski J. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro-oncology. 2013;74:1541-53. 

Kim J, Zhang Y, Skalski M, Hayes J, Kefas B, Schiff D, et al. microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma. Cancer Res. 2012, 5:1212-24.

Hayes JL, Tzika A, Thygesen H, Berri S, Wood HM, Hewitt S, et al. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation. Genomics. 2013;102:174–81. 

Hope IA, Stevens J, Garner A, Hayes J, Cheo DL, Brasch MA, et al. Feasibility of genome-scale construction of promoter::reporter gene fusions for expression in Caenorhabditis elegans using a multisite gateway recombination system. Genome Research. 2004;14:2070–5. 
